Apr 03, 2020 / 08:30AM GMT
Operator
Ladies and gentlemen, welcome to the Cosmo Pharmaceuticals Full Year Results 2019 Conference Call. I am Alessandro, the Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to the management team of Cosmo Pharmaceuticals. You will now be joining to the conference room.
Alessandro E. Della Chà - Cosmo Pharmaceuticals N.V. - CEO & Executive Director
Good morning, everyone. I am Alessandro Della Chà . I'm the CEO of the company. Thanks for joining our conference call, and thanks for taking time in this difficult moment. The first thing that I would like to convey, the first message that it's important that reaches out everyone is that we are in good shape. Cosmo is in very good shape, I would say. Cosmo, as a pharmaceutical company, first of all, is exempt from business shutdown provisions in Italy. Therefore, we are continuing business as usual. The production is up and running. Our drugs
Full Year 2019 Cosmo Pharmaceuticals NV Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers